| Record 6308 View: Standard | Glossary HistCite Guide |
|
Author(s): Hubbard SR
Title: Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog
Source: EMBO JOURNAL 16 (18): 5572-5581
Date: 1997 SEP 15
Document Type: Journal : Article
DOI:
Language: English
Comment:
Address: NYU,MED CTR,SKIRBALL INST BIOMOL MED,NEW YORK,NY 10016.
Reprint: Hubbard, SR, NYU,MED CTR,DEPT PHARMACOL,540 1ST AVE,NEW YORK,NY 10016.
E-mail:
Abstract: The crystal structure of the phosphorylated, activated form of the insulin receptor tyrosine kinase in complex with a peptide substrate and an ATP analog has been determined at 1.9 Angstrom resolution. The activation loop (A-loop) of the kinase undergoes a major conformational change upon autophosphorylation of Tyr1158, Tyr1162 and Tyr1163 within the loop, resulting in unrestricted access of ATP and protein substrates to the kinase active site. Phosphorylated Tyr1163 (pTyr1163) is the key phosphotyrosine in stabilizing the conformation of the tris-phosphorylated A-loop, whereas pTyr1158 is completely solvent-exposed, suggesting an availability for interaction with downstream signaling proteins. The YMXM-containing peptide substrate binds as a short anti-parallel beta-strand to the C-terminal end of the A-loop, with the methionine side chains occupying two hydrophobic pockets on the C-terminal lobe of the kinase. The structure thus reveals the molecular basis for insulin receptor activation via autophosphorylation, and provides insights into tyrosine kinase substrate specificity and the mechanism of phosphotransfer.
Cited References: BOSSEMEYER D, 1993, EMBO J, V12, P849 BRAMSON HN, 1984, CRC CRIT R BIOCHEM, V15, P93 BRUNGER AT, 1992, X PLOR VERSION 3 1 M CARSON M, 1991, J APPL CRYSTALLOGR 5, V24, P958 DICKENS M, 1992, BIOCHEM BIOPH RES CO, V186, P244 EBINA Y, 1985, CELL, V40, P747 ELLIS L, 1986, CELL, V45, P721 EVANS SV, 1993, J MOL GRAPHICS, V11, P134 FEENER EP, 1993, J BIOL CHEM, V268, P11256 FRANTZ JD, 1997, J BIOL CHEM, V272, P2659 HANKS SK, 1988, SCIENCE, V241, P42 HE WM, 1996, J BIOL CHEM, V271, P11641 HENDRICKSON WA, 1979, ACTA CRYSTALLOGR A, V35, P158 HOFSTRA RMW, 1994, NATURE, V367, P375 HUBBARD SR, 1994, NATURE, V372, P746 HUNTER T, 1982, J BIOL CHEM, V257, P4843 JONES TA, 1985, METHOD ENZYMOL, V115, P157 KATO H, 1994, MOL ENDOCRINOL, V8, P40 KHARITONENKOV A, 1995, J BIOL CHEM, V270, P29189 KNIGHTON DR, 1991, SCIENCE, V253, P407 KOHANSKI RA, 1993, BIOCHEMISTRY-US, V32, P5773 LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283 LONGATI P, 1994, ONCOGENE, V9, P49 MADHUSUDAN T, 1994, PROTEIN SCI, V3, P176 MIDDLEMAS DS, 1994, J BIOL CHEM, V269, P5458 MITRA G, 1991, ONCOGENE, V6, P2237 MOHAMMADI M, 1996, CELL, V86, P577 MOHAMMADI M, 1996, MOL CELL BIOL, V16, P977 NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157 NICHOLLS A, 1991, PROTEINS, V11, P281 NOEL JP, 1993, NATURE, V366, P654 ONEILL TJ, 1996, J BIOL CHEM, V271, P22506 OTWINOWSKI Z, 1993, P CCP4 STUD WEEK DAT, P56 PAI EF, 1990, EMBO J, V9, P2351 PANDIT SD, 1996, J BIOL CHEM, V271, P5850 ROSEN OM, 1983, P NATL ACAD SCI USA, V80, P3237 RUSSO AA, 1996, NAT STRUCT BIOL, V3, P696 SAWKAVERHELLE D, 1996, J BIOL CHEM, V271, P5980 SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027 SONGYANG Z, 1995, NATURE, V373, P536 STADTMAUER LA, 1983, J BIOL CHEM, V258, P6682 SUN XJ, 1991, NATURE, V352, P73 SUN XJ, 1993, MOL CELL BIOL, V13, P7418 TAVARE JM, 1988, BIOCHEM J, V253, P783 TAVARE JM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P21 TAYLOR SS, 1995, FASEB J, V9, P1255 TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212 ULLRICH A, 1985, NATURE, V313, P756 WEI L, 1995, J BIOL CHEM, V270, P8122 WHITE MF, 1988, J BIOL CHEM, V263, P2969 WHITE MF, 1994, J BIOL CHEM, V269, P1 YAMAGUCHI H, 1996, NATURE, V384, P484 ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362 |